Market research reports, consulting: Global Market Insights Inc.

Sinus Tissue Resection Devices Market Size – By Product Type, By Procedure, By Application, By End Use - Global Forecast, 2025 to 2034

Report ID: GMI12962
   |
Published Date: January 2025
 | 
Report Format: PDF

Download free sample

Sinus Tissue Resection Devices Market Size

The global sinus tissue resection devices market was valued at USD 1.1 billion in 2024 and is expected to exhibit growth at a CAGR of 6.7% from 2025 to 2034. Sinus tissue resection devices are specialized medical instruments used to remove or reduce obstructive tissue from the sinuses during surgical procedures.
 

Sinus Tissue Resection Devices Market

These devices, which include powered instruments like microdebriders and manual tools such as forceps and curettes, help improve sinus drainage and treat conditions such as chronic sinusitis and nasal polyps. The high market growth can be attributed to the increase in ENT surgeries, continuous advancements in surgical technology, and increased funding for research and development, among other contributing factors.
 

Moreover, the rising prevalence of chronic sinusitis and other sinus-related conditions has increased the demand for sinus tissue resection procedures. For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 31.2 million adults in the U.S. were diagnosed with sinusitis in 2021, representing 12.1% of the adult population. Environmental pollution, allergies, and lifestyle changes contribute to these disorders, further driving the need for sinus surgeries.
 

Furthermore, the development of minimally invasive surgical techniques, including endoscopic sinus surgery, has made sinus tissue resection procedures safer, more effective, and less painful. These advancements have improved patient outcomes and reduced recovery times, which drives market growth.
 

Sinus Tissue Resection Devices Market Trends

The market is witnessing significant growth, driven by continuous innovation, the surging need for integrated robotic-assisted surgery and automated systems, and the increased adoption of artificial intelligence in healthcare, among other factors that are boosting industry expansion.
 

  • One of the most significant trends in the market is the increasing demand for minimally invasive sinus surgeries. Techniques like endoscopic sinus surgery, which allow for precise tissue resection with smaller incisions, are gaining popularity. These procedures result in shorter recovery times, reduced complications, and better outcomes, thereby driving the demand for advanced sinus tissue resection devices.
     
  • Additionally, the use of computer-assisted navigation systems during sinus surgeries is on the rise. These systems provide real-time, high-resolution imaging and mapping, improving the accuracy and safety of tissue resection. Surgeons benefit from enhanced visualization of the anatomy, making procedures more efficient and reducing the risk of complications. These factors are expected to further propel market growth.
     

Sinus Tissue Resection Devices Market Analysis

Sinus Tissue Resection Devices Market, By Product Type, 2021 – 2034 (USD Billion)

Based on product type, the market is classified into surgical instruments, endoscopes, surgical navigation systems, and other product types. The surgical instruments segment generated the highest revenue of USD 472.8 million in 2024.
 

  • Innovations in surgical instruments for sinus tissue resection, including robotic-assisted systems, high-definition endoscopes, and laser technologies, have significantly enhanced precision and effectiveness. These advancements improve outcomes and enable safer, more efficient procedures. The growing demand for such sophisticated tools is especially evident in minimally invasive techniques.
     
  • Furthermore, there is a rising demand for customizable surgical instruments tailored to the specific needs of sinus surgery. Advanced instruments, such as modular forceps and specialized suction devices, are designed for greater adaptability during surgeries. The customization of surgical tools to fit specific patient requirements or surgeon preferences drives innovation and adoption in the market.
     

Based on procedure, the sinus tissue resection devices market is classified into functional endoscopic sinus surgery (FESS), balloon sinuplasty, Caldwell Luc surgery, and open sinus surgery. The FESS segment dominated the market in 2024 with a market share of 50.6%.
 

  • FESS offers superior surgical outcomes compared to traditional sinus surgeries. The use of endoscopes provides surgeons with clear, high-definition views of the sinuses and surrounding anatomy, enhancing precision during tissue resection. Consequently, FESS has demonstrated better outcomes, including improved sinus drainage, reduced symptom recurrence, and a lower complication rate.
     
  • Additionally, the ongoing advancement of endoscopic technology—including high-definition cameras, 3D imaging, and enhanced light sources—has significantly improved the effectiveness of FESS. These technological innovations enable surgeons to perform more precise procedures, driving FESS's growing popularity and adoption in sinus tissue resection. This trend is expected to propel growth in this segment of the market.
     

Based on application, the sinus tissue resection devices market is classified into chronic sinusitis, recurrent acute sinusitis, benign sinus tumors, and other applications. The chronic sinusitis segment accounted for USD 495.5 million in market revenue in 2024 and is anticipated to grow at a CAGR of 6.2% between the 2025 to 2034 period.
 

  • Chronic sinusitis is among the most prevalent long-term conditions globally, affecting millions and causing persistent nasal congestion, facial pain, pressure, and headaches. The increasing incidence of this condition, often attributed to factors such as allergies, environmental pollution, respiratory infections, and anatomical abnormalities, drives the demand for effective treatments. Given that chronic sinusitis is frequently challenging to manage with medications alone, surgical intervention becomes essential, propelling the market for sinus tissue resection devices.
     
  • Many chronic sinusitis patients exhibit poor responses to standard treatments, including antibiotics, nasal corticosteroids, or saline irrigation, limiting the long-term efficacy of conservative approaches. This compels patients and healthcare providers to explore surgical options, such as sinus tissue resection. The growing need for more durable solutions for managing chronic sinusitis drives the demand for advanced sinus surgery tools, thereby contributing to the growth of this segment.
     
Sinus Tissue Resection Devices Market, By End Use (2024)

Based on end use, the sinus tissue resection devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 1.1 billion by the end of the forecast period.
 

  • Hospitals are increasingly adopting advanced technologies in sinus tissue resection devices, such as high-definition endoscopes, advanced imaging systems, 3D navigation tools, and robotic-assisted surgery systems. These innovations enhance surgical precision, safety, and efficiency, addressing hospitals' demands for equipment that improves patient outcomes. The continuous advancement of surgical devices serves as a key driver for hospital adoption in this market.
     
  • Additionally, the growing preference for minimally invasive surgical procedures is fueling demand for specialized devices. Procedures like Functional Endoscopic Sinus Surgery (FESS) offer significant advantages, including reduced patient trauma, quicker recovery times, less pain, and fewer complications. Hospitals are increasingly adopting these techniques, further driving the market for devices that enable precise and minimally invasive sinus surgeries.

     
U.S. Sinus Tissue Resection Devices Market, 2021 – 2034 (USD Million)

U.S. sinus tissue resection devices market accounted for USD 406.7 million market revenue in 2024 and is anticipated to grow at a CAGR of 6.1% between the 2025 to 2034 period.
 

  • The U.S. boasts a highly developed healthcare infrastructure, featuring state-of-the-art medical facilities, research institutions, and hospitals. This robust framework supports the adoption of cutting-edge technologies essential for performing accurate and effective surgeries. Healthcare institutions in the U.S. are early adopters of innovative medical technologies, driving the demand for advanced sinus resection devices.
     
  • Additionally, the U.S. market leads in the development and integration of advanced medical technologies. Innovations such as high-definition endoscopic systems, 3D imaging, robotic surgical tools, and computer-assisted navigation systems have significantly enhanced the precision of sinus surgeries and improved patient outcomes. These advancements make sinus tissue resection procedures safer and more effective, boosting their adoption rates across the country.
     

Germany sinus tissue resection devices market is projected to grow remarkably in the coming years.
 

  • Germany’s market is projected to grow remarkably in the coming years. The country’s healthcare system is highly developed, with public health insurance covering most medical treatments, including surgeries for chronic sinusitis and other sinus disorders. This extensive coverage, combined with reimbursement policies for advanced procedures like FESS, makes these treatments financially accessible to a wide population.
     
  • Furthermore, the government’s commitment to high-quality healthcare drives hospitals to adopt state-of-the-art surgical technologies. This focus on innovation promotes investments in advanced sinus tissue resection devices, which enhance precision and outcomes in sinus surgeries. Together, these factors contribute to the robust growth of the market in Germany.
     

Japan holds a dominant position in the Asia Pacific sinus tissue resection devices market.
 

  • Japan holds a dominant position in the Asia-Pacific market. The country’s rapidly aging population, with a significant proportion aged 65 and above, drives market demand. Older individuals are more prone to chronic sinusitis, nasal polyps, and other sinus conditions requiring surgical intervention, fueling the need for sinus tissue resection procedures.
     
  • Additionally, Japan excels in medical device manufacturing, particularly in surgical tools. Sinus tissue resection devices produced in Japan incorporate advanced technologies such as HD endoscopes, 3D imaging, robotics, and computer navigation. These features enhance the safety and accuracy of surgeries, leading to increased adoption of these devices in hospitals nationwide.
     

Sinus Tissue Resection Devices Market Share

The market is highly competitive, with key players offering advanced surgical instruments and devices for sinus surgeries. Major companies in this space include Medtronic, Stryker, Johnson & Johnson, and B. Braun, among others. These companies compete on innovation, product quality, and expanding their market presence through strategic acquisitions, partnerships, and R&D investments. Additionally, the increasing focus on minimally invasive procedures and advanced surgical technologies fuels competition within the market.
 

Sinus Tissue Resection Devices Market Companies

Prominent players operating in the sinus tissue resection devices industry include:

  • Acclarent
  • B. Braun
  • Bien-Air
  • Cook Medical
  • INTEGRA
  • Medtronic
  • Meril
  • OLYMPUS
  • Osteogenics
  • PENTAX MEDICAL
  • STILLE
  • Stryker
  • SUMMIT MEDICAL
  • SURTEX
  • XELPOV SURGICAL
     

Sinus Tissue Resection Devices Industry News:

  • In March 2024, Olympus has expanded its ENT portfolio with the launch of the CELERIS single-use sinus debrider system and Celon Elite, targeting outpatient care for rhinology procedures. These innovations support the transition of non-urgent surgeries, such as polypectomies and functional endoscopic sinus surgery, from ORs to office settings. This system, uniquely positioned as the only single-use sinus debrider, enhances efficiency in ENT procedures.
     

The sinus tissue resection devices market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Product Type

  • Surgical instruments
  • Endoscopes
  • Surgical navigation systems
  • Other product types

Market, By Procedure

  • Functional endoscopic sinus surgery (FESS)
  • Balloon sinuplasty
  • Caldwell Luc surgery
  • Open sinus surgery

Market, By Application

  • Chronic sinusitis
  • Recurrent acute sinusitis
  • Benign sinus tumors
  • Other applications

Market, By End Use

  • Hospitals
  • Specialty clinics
  • Ambulatory surgical centers
  • Other end users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
How big is the sinus tissue resection devices market?
The global sinus tissue resection devices industry was valued at USD 1.1 billion in 2024 and is projected to grow at a CAGR of 6.7% from 2025 to 2034, driven by advancements in minimally invasive surgical techniques.
Why is the demand for advanced surgical instruments rising?
Who are some of the prominent players in the sinus tissue resection devices industry?
What is the size of the U.S. sinus tissue resection devices industry?
Sinus Tissue Resection Devices Market Scope
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,280 $5,350
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2024

    Companies covered: 15

    Tables & Figures: 138

    Countries covered: 19

    Pages: 140

    Download Free Sample

    Top